Envy Medical, Inc., a Westlake Village CA-based provider of professional skincare products and services, secured new growth capital from HCP & Company, a middle-market private equity firm headquartered in Chicago.
The amount of the deal was not disclosed.
The company intends to use the funds for sales and marketing initiatives, as well as for development and introduction of new skincare offerings.
Led by Curtis A. Cluff, Chief Executive Officer, and Ken Karasiuk, Founder and Chairman of the Board, Envy Medical develops, markets and sells non-invasive skin rejuvenation therapies for patients suffering from either dermatologic or aesthetic conditions. Its lead products include SilkPeel®, a device combining exfoliation with Dermalinfusion® for deeper tissue delivery of active ingredients and better patient outcomes.
The company is also the exclusive global licensor of skin brightening peptides including Lumixyl®, developed at Stanford University, which is now also available as a topical solution for SilkPeel procedures, addressing hyperpigmentation and photo-damage.